4D Molecular Therapeutics is giving 21,800 restricted stock units to a new employee as a signing bonus.

Nov 13, 2026, 5:37 PM ETNew sharesRead the original at globenewswire.com

Neutral

4D Molecular Therapeutics granted 21,800 restricted stock units to one new employee outside its existing plans. The report gives no change to its drug results or business outlook.

FDMT · 4D Molecular Therapeutics

AI read · Neutral

The AI's read

This is a hiring compensation item, not a report on a drug study or sales. It covers one employee, and the report gives no share-count comparison or business result. So it does not show a change to the company's outlook.

Get alerts for FDMT

Follow 4D Molecular Therapeutics (FDMT) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for FDMT

Free on the App Store and Google Play, or on the web.